Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| 1 |
Apple
AAPL
|
+$1.18B |
| 2 |
Microsoft
MSFT
|
+$1.11B |
| 3 |
ALXN
Alexion Pharmaceuticals Inc
ALXN
|
+$491M |
| 4 |
Technology Select Sector SPDR Fund
XLK
|
+$464M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$442M |
Top Sells
| 1 |
iShares US Real Estate ETF
IYR
|
+$1.2B |
| 2 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$779M |
| 3 |
DuPont de Nemours
DD
|
+$443M |
| 4 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$359M |
| 5 |
Invesco QQQ Trust
QQQ
|
+$323M |
Sector Composition
| 1 | Technology | 22.43% |
| 2 | Financials | 13.7% |
| 3 | Consumer Discretionary | 10.25% |
| 4 | Communication Services | 9.85% |
| 5 | Healthcare | 9.36% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1601
Haemonetics
HAE
$2.51B
| $2.82M | ﹤0.01% |
25,399
+23,993
| +1,706% | +$2.66M |
|
|
NSTG
1602
DELISTED
NanoString Technologies, Inc.
NSTG
| $2.82M | ﹤0.01% |
42,904
-83,946
| -66% | -$5.52M |
|
1603
Trinity Industries
TRN
$2.28B
| $2.81M | ﹤0.01% |
98,533
+92,992
| +1,678% | +$2.65M |
|
|
VRE
1604
Veris Residential
VRE
$1.49B
| $2.81M | ﹤0.01% |
181,135
+67,439
| +59% | +$1.04M |
|
1605
Middleby
MIDD
$6.82B
| $2.8M | ﹤0.01% |
16,901
-250,070
| -94% | -$41.4M |
|
1606
NBT Bancorp
NBTB
$2.27B
| $2.8M | ﹤0.01% |
70,228
+22,312
| +47% | +$890K |
|
1607
Enpro
NPO
$4.64B
| $2.8M | ﹤0.01% |
32,825
+8,052
| +33% | +$687K |
|
1608
Supernus Pharmaceuticals
SUPN
$2.55B
| $2.8M | ﹤0.01% |
106,758
-13,929
| -12% | -$365K |
|
1609
iShares 0-5 Year High Yield Corporate Bond ETF
SHYG
$7.29B
| $2.79M | ﹤0.01% |
+60,961
| New | +$2.79M |
|
1610
Evertec
EVTC
$2.14B
| $2.79M | ﹤0.01% |
74,977
+8,667
| +13% | +$323K |
|
|
AQUA
1611
DELISTED
Evoqua Water Technologies Corp. Common Stock
AQUA
| $2.79M | ﹤0.01% |
106,063
+66,945
| +171% | +$1.76M |
|
|
VGR
1612
DELISTED
Vector Group Ltd.
VGR
| $2.79M | ﹤0.01% |
281,853
+67,378
| +31% | +$666K |
|
1613
Eagle Bancorp
EGBN
$615M
| $2.79M | ﹤0.01% |
52,383
+16,798
| +47% | +$894K |
|
1614
Adaptive Biotechnologies
ADPT
$1.92B
| $2.78M | ﹤0.01% |
69,090
-32,850
| -32% | -$1.32M |
|
1615
United Therapeutics
UTHR
$18.3B
| $2.78M | ﹤0.01% |
16,626
+9,579
| +136% | +$1.6M |
|
1616
Astec Industries
ASTE
$1.06B
| $2.78M | ﹤0.01% |
36,872
-9,639
| -21% | -$727K |
|
1617
Papa John's
PZZA
$1.65B
| $2.78M | ﹤0.01% |
31,362
+16,344
| +109% | +$1.45M |
|
|
ALEX
1618
Alexander & Baldwin
ALEX
$1.34B
| $2.76M | ﹤0.01% |
164,610
+80,090
| +95% | +$1.34M |
|
1619
Hamilton Lane
HLNE
$6.53B
| $2.76M | ﹤0.01% |
31,181
-14,073
| -31% | -$1.25M |
|
1620
Melco Resorts & Entertainment
MLCO
$3.75B
| $2.75M | ﹤0.01% |
138,294
-346,401
| -71% | -$6.9M |
|
|
BHVN
1621
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
| $2.75M | ﹤0.01% |
40,248
-79,389
| -66% | -$5.43M |
|
1622
Quanex
NX
$661M
| $2.75M | ﹤0.01% |
104,856
+8
| +0% | +$210 |
|
1623
Progress Software
PRGS
$1.81B
| $2.75M | ﹤0.01% |
62,425
-6,875
| -10% | -$303K |
|
|
CDK
1624
DELISTED
CDK Global, Inc.
CDK
| $2.74M | ﹤0.01% |
50,676
-13,514
| -21% | -$731K |
|
|
OPI
1625
Office Properties Income Trust
OPI
$40.8M
| $2.74M | ﹤0.01% |
99,512
+36,061
| +57% | +$992K |
|